Predicting Human Subcutaneous Bioavailability of Therapeutic Monoclonal Antibodies from Systemic Clearance and Volume of Distribution
Year: 2024
Type: article
Source: Molecular Pharmaceutics
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Merck
OpenAlex ID: W4402186907
